RT-310

COMBINATION_PRODUCT2 trials

Sponsors

Resurge Therapeutics Inc.

Conditions

BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms

Phase 1

RT-310 Dose Escalation BPH Study

Active, not recruitingNCT06136819

Resurge Therapeutics Inc.BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms

Start: 2024-04-19End: 2027-12-31Target: 20Updated: 2025-11-28

RT-310 Safety and Feasibility BPH Study

Active, not recruitingNCT07264205

Resurge Therapeutics Inc.BPH (Benign Prostatic Hyperplasia)

Start: 2025-03-13End: 2026-06-01Target: 20Updated: 2026-03-20